Loading stock data…
SANUWAVE Health, Inc. (SNWV)
$9.85+1.24 (+14.40%)
Market ClosedLast close Jun 29
SANUWAVE Health, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
SANUWAVE Health, Inc. in the Healthcare sector is trading at $9.85 with a market capitalization of $85M. The stock is currently near its 52-week low of $7.53, remaining 60.6% below its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 31) — potential for technical mean-reversion
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $9.62M↓ | $13.09M↑ | $11.45M↑ | $10.16M↑ | $9.33M |
| Gross Profit | $7.43M↓ | $9.70M↑ | $8.93M↑ | $7.96M↑ | $7.38M |
| Operating Income | -$1.12M↓ | $615,000↓ | $1.47M↓ | $1.88M↑ | $601,000 |
| Net Income | -$1.44M↓ | $6.11M↓ | $10.32M↑ | $1.05M↑ | -$6.12M |
Peer Comparison
JNJUNHPFE
Fundamentals
SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$84.70M
P/E Ratio
Value territory. Trading at a high yield relative to earnings.
10.26
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.34
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
873.23%
Volume
Today's trading volume
262,318
Recent News
Top Midday Decliners
Sanuwave Health's (SNWV) Q2 revenue is expected to be in the range of $8.5 million to $9.5 million,
SANUWAVE Health Inc (SNWV) Q1 2026 Earnings Call Highlights: Record Revenue Amid Market Challenges
SANUWAVE Health Inc (SNWV) reports its highest Q1 revenue ever, despite facing pricing challenges and increased operating expenses.
Sanuwave Health Q1 Earnings Call Highlights
Sanuwave Health (NASDAQ:SNWV) reported record first-quarter revenue and rising consumables utilization, while management said the advanced wound care market began to recover after a difficult start to the year tied to changes in reimbursement for skin substitutes. Chairman and CEO Morgan Frank said
SANUWAVE Health Inc Reports Q1 2026 Results: Full Earnings Call Transcript
SANUWAVE Health Inc (OTC:SNWV) released first-quarter financial results and hosted an earnings call on Wednesday. Read the complete transcript below. This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit https://www.benzinga.com/apis/ for a consultation. The full earnings call is available at https://viavid.webcasts.com/starthere.jsp?ei=1762392&tp_key=537d7338d6 Summary SANUWAVE Health Inc reported record Q1 revenues of $9.6 million, a 3% in
SANUWAVE Health, Inc. Q1 2026 Earnings Call Summary
Moby summary of SANUWAVE Health, Inc.'s Q1 2026 earnings call